Pharmicell Co. Ltd.
Company Snapshot
Founded: 1968
Entity Type: Public
Region: South Korea
Headquarter: South Korea
Key Geographics: South Korea
Corporate Address: 7th floor, Ssangbong Building 874 Unju-ro, Gangnam-gu Seoul-si, South Korea Tel. +82-2-3496-0114 www.pharmicell.com
Company Overview
Pharmicell operates in two business segments: Biopharmaceutical and Biochemical. In the Biopharmaceutical division, the company develops stem cell drugs such as mesenchymal stem cells and dendritic cells for the treatment of heart disease, liver diseases, chronic kidney diseases, prostate and ovarian cancer. The company also provides stem cell banking services for adult stem cells and cord-blood. It provides CMO services for researchers to accelerate the development of stem cell therapeutics. The company has developed cosmetic products using stem cell culture technology.
Pharmicell Co. Ltd. In Reports
Pharmicell Co. Ltd. In News
Company's Business Segments
- Biopharmaceutical : This segment engaged in stem cell banking based on various accumulated course of drug development of stem cell drugs.
- Biochemical : This segment provides flame retardants and raw material medicines such as Nucleoside, mPEG, HDP-tosylate, and Vincelactam.
Applications/End User Industries
- Biopharmaceuticals
BCC Research Beacon 